←
Zinaida Good68 posts
Zinaida Good avatar

Zinaida Good

@GoodZinaida

Assistant Professor of Medicine at Stanford University

◷ Joined December 2014▧ 3 Photos and videos
Zinaida Good avatar
Zinaida Good@GoodZinaida·Jul 6

H&E pathology and natural text are linked through gene expression using contrastive learning to enable pathology-text linkage where groud truth data is scarce.

Post attachment
Zinaida Good avatar
Zinaida Good@GoodZinaida·Jul 6

We're excited to release SpatialWhisperer, a trimodal model for zero-shot annotation of histopathology images at #ICML2026! This work is lead by Moritz Schaefer @muronglizi.

Cancer diagnosis is informed by cellular annotations of histopathology, but assays are expensive or rely on manual annotations. At #ICML2026, we present SpatialWhisperer, a trimodal model that zero-shot annotates cell types in histopathology images. 🧵👇

Post attachment
Zinaida Good avatar
Zinaida Good@GoodZinaida·Apr 17

Grateful to the Stanford Center for Digital Health for supporting our work with @jure on prototyping AI models and agents for T cell therapy design.

We're excited to introduce the 2026 Stanford Center for Digital Health Grant Awardees, a cohort of scientists working on projects that can transform health. Please join us in celebrating this exceptional group of researchers from across @stanford. cdh.stanford.edu/research-po…

0:06
Laude Institute avatar
⟳ Zinaida Good retweeted
Laude Institute@LaudeInstitute·Apr 15

We asked the best AI researchers in the world one question: if you had the resources, how would you use AI to solve humanity's hardest problems? Today we're sharing what came back. Moonshots // ONE is live. 🧵 laude.org/moonshots

0:09
Roth_Lab avatar
⟳ Zinaida Good retweeted
Roth_Lab@Roth_Lab·21 Nov 2025

Excited to present the first major work after starting our lab at Stanford and the Arc this year: CRISPR-All, a unified genetic perturbation language for programming any major type of genetic perturbation simultaneously, in any combination, at genome scale, in human cells.

Zinaida Good avatar
Zinaida Good@GoodZinaida·1 Nov 2025

It's exciting to share our mini-review on #Treg cell therapies out today in Frontiers in Immunology! Earning a #NobelPrize this year, Tregs have been tested in >69 clinical trials and are moving towards initial approvals. frontiersin.org/journals/imm…

Zinaida Good avatar
Zinaida Good@GoodZinaida·7 Jan 2025

Today is my first day as an Assistant Professor of Medicine at Stanford University! My research program is focused on understanding and enhancing engineered T cell immunotherapies for cancer and immune-mediated diseases. If interested in joining please reach out!

Zinaida Good avatar
Zinaida Good@GoodZinaida·7 Dec 2024

Very proud of Anne Marijn Kramer to present 2 orals and a poster at #ASH2024, especially our work on CD22-CAR! Session 702 Dec 9 at 2:45 PM San Diego Convention Center, Room 6CF Title: CD22-Directed CAR T Cell Single Cell Multiomic Features Associated with IEC-HS

Zinaida Good avatar
Zinaida Good@GoodZinaida·7 Dec 2024

So proud of Kelvin Mo to give his first talk at #ASH2024! Session 702 Dec 7 at 4:00 PM Manchester Grand Hyatt San Diego, Grand Hall C Title: CCL8/CCL13-Producing Tumor-Associated Macrophages Linked to Poor Outcomes after CAR T Cell Therapy for LBCL

Zinaida Good avatar
Zinaida Good@GoodZinaida·7 Dec 2024

What an honor to give my first invited talk at #ASH2024. I am so grateful to my mentors Crystal Mackall, Sylvia Plevritis, and David Miklos for enabling me to get here! Dec 8 at 4:30 PM, San Diego Conv. Center, Room 33 Cellular Heterogeneity and Relationship to Clinical Outcomes